Publications

5808 Results

Validation of the DNA Damage Immune Response (DDIR) Signature in Triple-Negative Breast Cancer (TNBC) Patients from the SWOG 9313c Trial

Authors
P Sharma;W Barlow;A Godwin;E Parkes;L Knight;SM Walker;RD Kennedy;D Harkin;G Logan;CJ Steele;S Lambe;S Badve;Y Gokmen-Polar;H Pathak;K Isakova;HM Linden;P Porter;L Pusztai;AM Thompson;D Tripathy;G Hortobagyi;D Hayes
Journal / Conference
Journal of Clinical Oncology Dec 20;37(36):3484-3492; Oct 28[Online ahead of print]
Year
2019
Research Committee(s)
Breast
PMID
PMID31657982
PMC
PMC7194448
Study Number(s)
SWOG-9313

Impact of Adjuvant Trastuzumab on Locoregional Failure Rates in the NCCTG N9831 (Alliance) Study

Authors
C Thorpe;C Vargas;A Dueck;K Tenner;E Perez;ES Hwang;M Halyard;T Pisansky;S Martino;N Davidson;B Pockaj
Journal / Conference
ASTRO Annual Meeting (9/15-18/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Breast
Study Number(s)
N9831

Fractures in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG S0307 trial (ClinicalTrials.gov Identifier: NCT00127205)

Authors
R Yung;J Miao;AHG Paterson;M Clemons;E Dees;JN Ingle;CI Falkson;W Barlow;G Hortobagyi;J Gralow
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 10-14, 2019, San Antonio, TX), P2-18-03, poster
Year
2019
Research Committee(s)
Breast
Study Number(s)
S0307

Baseline Factors Associated with Aromatase Inhibitor Adherence Failure among Women in Enrolled in a Randomized Trial of Text-Messaging: SWOG S1105

Authors
DL Hershman;JM Unger;A Moseley;G Clarke Hillyer;K Arnold;JR Gralow;NL Henry;S Ramsey;A Neugut
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 10-14, 2019, San Antonio, TX), poster, spotlight session
Year
2019
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1105

Increasing lengths of first complete remission with 7+3 induction chemotherapy for acute myeloid leukemia over the past four decades: Analysis of SWOG trial data

Authors
M Othus;G Garcia-Manero;JE Godwin;JK Weick;F Appelbaum;H Erba;E Estey
Journal / Conference
Blood (2019) 134 (Supplement_1): 291, abst 613 (American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), oral
Year
2019
Research Committee(s)
Leukemia
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333

Alliance A041701 - A randomized phase 2/3 study of conventional chemotherapy +/- uproleselan (GMI-1271) in older adults with acute myeloid leukemia receiving intensive induction chemotherapy

Authors
G Uy;V Yin;H Klepin;S Dinner;A Jaslowski;SA Strickland;J Liesveld;J Byrd;RM Stone
Journal / Conference
Blood (2019) 134 (Supplement_1): 1366. American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), TIPS, poster
Year
2019
Research Committee(s)
Leukemia

Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)

Authors
M Smith;O Jegede;SS Parekh;C Hanson;F Kuhr;P Martin;B Till;M Crump;JP Leonard;JW Friedberg;B Kahl;T Witzig
Journal / Conference
Blood (2019) 134 (Supplement_1): 751, abst 623; American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), oral
Year
2019
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1411

Factors That Potentially Impact Lenalidomide/R-CHOP (R2-CHOP) Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies

Authors
G Nowakowski;A Chiappella;F Hong;R Gascoyne;DW Scott;W Macon;RL King;JE Amengual;RF Little;JP Leonard;JW Friedberg;L Kostakoglu;W Jurczak;K Yamamoto;M Czuczman;J Russo;K Hudak;J Zhang;S Wade;T Witzig;BS Kahl;U Vitolo
Journal / Conference
Blood (2019) 134 (Supplement_1): 4092, abst 626; American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), poster
Year
2019
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1412

PET-Directed Therapy for Patients with Limited-Stage Diffuse Large B-Cell Lymphoma - Results of Intergroup NCTN Study S1001

Authors
D Persky;H Li;D Stephens;SI Park;NL Bartlett;L Swinnen;P Barr;J Winegarden;L Constine;TJ Fitzgerald;JP Leonard;BS Kahl;M Leblanc;J Song;RI Fisher;L Rimsza;SM Smith;JW Friedberg
Journal / Conference
Blood (2019) 134 (Supplement_1): 349; American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), oral
Year
2019
Research Committee(s)
Lymphoma
Study Number(s)
S1001

Intraclonal Heterogeneity Caused by Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: an Analysis of SWOG S0016

Authors
WR Burack;H Li;D Adlowitz;J Spence;L Rimsza;R Braziel;C Spier;M Kaminski;JP Leonard;RI Fisher;M Leblanc;SM Smith;JW Friedberg
Journal / Conference
Blood (2019) 134 (Supplement_1): 2771; American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL), poster
Year
2019
Research Committee(s)
Lymphoma
Study Number(s)
S0016